Event Centre
Event Centre
The Event Centre is your hub for full session recordings and expert highlights from our medical education events over the years, offering a comprehensive archive of learning and insights.
.png?width=1208&height=908&format=webp&quality=50)
ESMO 2025
Watch the expert panel including Dr. Elena Castro, Prof. Dr. Axel Heidenreich and Dr. Alejo Rodríguez-Vida discuss key considerations in GU care.
The Power of Precision Medicine: Transforming Patient Outcomes in GU Oncology - Full session video
Expert highlights
Optimising outcomes: Patient-centred care in mHSPC
Dr. Alejo Rodríguez-Vida explores optimising patient-centred care in mHSPC, including treatment personalisation and insights from recent clinical analyses.
Timely testing in prostate cancer: Addressing the unmet needs
Prof. Dr. Axel Heidenreich highlights the importance of early genomic testing to guide treatment decisions for patients with mHSPC and HRR mutations.
Hear from the Experts – Discussions filmed at ESMO 2025
Dr. Elena Castro
Dr. Elena Castro discusses how genetic testing, treatment personalisation, and biomarker-driven strategies can address unmet needs in mHSPC while balancing rapid clinical advances with practical implementation challenges.
Prof. Dr. Axel Heidenreich
Prof. Dr. Axel Heidenreich addresses the role of molecular testing, emerging trial data, and strategies to advance personalised, patient-centred care across the prostate cancer journey.
Dr. Alejo Rodríguez-Vida
Dr. Alejo Rodríguez-Vida examines how emerging data and research can guide personalised treatment, address unmet needs, and shape the future of care for patients with mHSPC.
UROonco 2025
Watch below as Dr. Miguel Ramírez-Backhaus, Prof. Jozefina Casuscelli and Prof. Gert Attard explore the importance of early detection and screening in metastatic prostate cancer.
(Bio) Markers and milestones at the crossroads in mHSPC care - Full session video
Hear from the Experts – Discussions filmed at UROonco 2025
Dr. Miguel Ramírez-Backhaus
Dr. Miguel Ramírez-Backhaus discusses the value of real-world data, decision-making around doublets versus triplets, and the importance of shared decision making for patient outcomes.
Prof. Jozefina Casuscelli
Prof. Jozefina Casuscelli outlines barriers to overcome for biomarker-driven care, the combination of PSA dynamics with other key factors for fully informed treatment decisions, and the value of collaboration between healthcare professionals and with patients.
Prof. Gert Attard
Prof. Gert Attard explores the clinical implications of the CAPTURE and AMPLITUDE studies, the role of shared decision making to balance survival advantage with toxicity, and choosing the right treatment for the right patient.
The recorded content may not be available in your country. To request access to recordings and session materials, please contact our team.
Contact us
To report an Adverse Event (medication side effect) or a Product Quality Complaint (an issue with one of our products), please select the appropriate link from the Contact dropdown menu. To submit a medical information request, choose the Medical Information page.
Abbreviations
GU, genitourinary; HRR, homolgous recombinant repair; mHSPC, metastatic hormone-sensitive prostate cancer; PSA, prostate-specific antigen.
CP-554489 - December 2025
Janssen Pharmaceutica NV